Deferasirox
These highlights do not include all the information needed to use DEFERASIROX TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for DEFERASIROX TABLETS FOR ORAL SUSPENSION. DEFERASIROX tablets, for oral suspension Initial U.S. Approval: 2005
e365e748-4b61-94f2-fb7a-f81919eaccaa
HUMAN PRESCRIPTION DRUG LABEL
Dec 30, 2020
Dr. Reddy's Laboratories Inc
DUNS: 802315887
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Deferasirox
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
Deferasirox
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
Deferasirox
Product Details
FDA regulatory identification and product classification information